Covidien PLC (NYSE: COV) said Monday it will buy brain monitoring technology company Aspect Medical Systems Inc. (NASDAQ: ASPM) for about $210 million, according to Associated Press.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
The move is meant to broaden the drug and medical device maker's product portfolio.
Covidien will pay $12 per share for Aspect, marking a 56 percent premium to Aspect's closing price of $7.67 Friday. The deal should close by the end of the year.
The buyout comes a week after Covidien completed the sale of its sleep diagnostics unit assets to Embla Systems for an undisclosed amount. The company said it made the sale as part of a shift to focus more on its higher-margin businesses.
Covidien also laid off 70 people at a medical supplies plant in Norfolk, NE last week as part of a restructuring move. The plant makes syringes and blood-collection tubes and will have 360 employees when the layoffs are complete in April. Covidien has more than 41,000 employees worldwide.
Covidien said it expects a charge related to the acquisition of Aspect Medical to cut into its earnings-per-share in 2010.
Shares of Covidien moved up $1.04, or 2.5 percent, to $42.40 on Friday.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
